how do the glp 1 drugs work Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Understanding the Side Effects of

However, what sets Mounjaro apart is its dual-agonist action, as it activates both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors simultaneously

Results from these studies, expected in the coming years, will provide critical evidence regarding the potential neuroprotective effects of GLP-1 therapy

Key lifestyle changes, including dietary adjustments, increased physical activity, and behavioural therapy, are foundational to obesity management

Strengths and limitations Our study had several strengths

These findings represent substantial improvements over traditional anti-obesity medications and approach the efficacy levels historically associated with bariatric surgery